Endoscopy
DOI: 10.1055/a-2665-1777
Innovations and brief communications

Regenerative endoscopy for the treatment of difficult gastrointestinal defects: results from a pilot trial

Authors

  • Dania Nachira

    1   Department of General Thoracic Surgery, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy
  • Valerio Pontecorvi

    2   Digestive Endoscopy Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy
  • Angelo Trivisonno

    3   Unit of Plastic Surgery, Assunzione di Maria Santissima Clinic, Rome, Italy
  • Massimiliano Papi

    4   Dipartimento di Neuroscienze, Università Cattolica del Sacro Cuore, Roma, Italy
    5   Fondazione Policlinico Universitario Agostino Gemelli IRCSS, Rome, Italy
  • Maria Valeria Matteo

    2   Digestive Endoscopy Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy
  • Vincenzo Bove

    2   Digestive Endoscopy Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy
  • Martina De Siena

    2   Digestive Endoscopy Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy
  • Loredana Gualtieri

    2   Digestive Endoscopy Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy
  • Anna Amelia Caretto

    6   Plastic and Reconstructive Surgery, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
  • Stefano Gentileschi

    6   Plastic and Reconstructive Surgery, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
  • Gabriele Toietta

    7   Department of Research, Advanced Diagnostic, and Technological Innovation, Translational Research Area, IRCCS Regina Elena National Cancer Institute, Rome, Italy
  • Francesco Fanfani

    8   Dipartimento per la Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
    9   Dipartimento di Scienze della Vita e Sanità Pubblica, Università Cattolica del Sacro Cuore, Rome, Italy
  • Giovanni Scambia

    8   Dipartimento per la Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
    9   Dipartimento di Scienze della Vita e Sanità Pubblica, Università Cattolica del Sacro Cuore, Rome, Italy
  • Guido Costamagna

    10   Digestive Endoscopy, Ospedale Isola Tiberina – Gemelli Isola, Rome, Italy
  • Stefano Margaritora

    1   Department of General Thoracic Surgery, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy
  • Cristiano Spada

    2   Digestive Endoscopy Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy
    11   Università Cattolica del Sacro Cuore, Rome, Italy
  • Ivo Boskoski

    2   Digestive Endoscopy Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy
    11   Università Cattolica del Sacro Cuore, Rome, Italy

Clinical Trial:

Registration number (trial ID): NCT04670276, Trial registry: ClinicalTrials.gov (http://www.clinicaltrials.gov/), Type of Study: Prospective



Graphical Abstract

Preview

Abstract

Background

Gastrointestinal (GI) defects with inflamed, fibrotic edges are often refractory to traditional endoscopic treatments. This study evaluates the efficacy and safety of endoscopically delivered stromal vascular fraction from autologous adipose tissue (tSVFem), which promotes tissue regeneration in upper and lower GI defects without additional patient risk or cost.

Methods

This pilot trial involved patients with GI defects accessible by endoscopy after traditional treatments had failed. The tSVFem was derived from harvested hip fat, which was processed and injected endoscopically into the defect margins. The primary outcome was complete defect resolution. Secondary outcomes included treatment frequency, procedure-related adverse events, and recurrence.

Results

30 patients were included: 15 with esophageal defects (median diameter 6 mm) and 15 with rectal defects (median diameter 5 mm). Of the 15 esophageal defects, 14 showed complete resolution after tSVFem injection (10 after one injection and 4 after two injections). The overall resolution rate for rectal defects was 60% (six after one treatment, one after two treatments, and two after three or four treatments). The resolution rate was 5/9 for rectal defects communicating with the urinary tract and 4/6 for those communicating with other organs. No intraprocedural or postprocedural adverse events or defect recurrence occurred.

Conclusions

These results suggest that endoscopic injection of autologous tSVFem may treat complex esophageal and rectal defects, including those communicating with adjacent organs other than the urinary tract.

Supplementary Material



Publikationsverlauf

Eingereicht: 05. März 2025

Angenommen nach Revision: 24. Juli 2025

Accepted Manuscript online:
24. Juli 2025

Artikel online veröffentlicht:
09. September 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany